Vericel Signs Distribution Agreement with Orsini Pharmaceutical

Vericel (VCEL) entered into a 2-year renewable agreement with Orsini Pharmaceutical for distribution of Carticel® and MACI® in the U.S. and Puerto Rico. Orsini will work with Vericel’s service provider, Pro-Spectus, for management of patient cases related to the products.

Concurrently, VCEL announced the pending June 2017 termination of an...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us